Karyopharm Therapeutics Inc. (KPTI) - NASDAQ
Company Description
Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. Its selective inhibitors of nuclear export... More
Sector: Healthcare
Industry: Drug Manufacturers - Major
Country: United States